BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $544,000 | -0.9% | 3,950 | 0.0% | 0.18% | -8.5% |
Q3 2021 | $549,000 | +7.6% | 3,950 | -24.8% | 0.20% | +6.4% |
Q2 2021 | $510,000 | +2.8% | 5,250 | -27.6% | 0.19% | -3.6% |
Q1 2021 | $496,000 | -1.0% | 7,250 | +23.9% | 0.20% | -9.7% |
Q4 2020 | $501,000 | +31.8% | 5,850 | 0.0% | 0.22% | +16.1% |
Q3 2020 | $380,000 | +118.4% | 5,850 | -57.5% | 0.19% | +104.4% |
Q2 2020 | $174,000 | – | 13,750 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |